Evidence map

ReviewTherapeutic advances in endocrinology and metabolism2019

A review of sotagliflozin for use in type 1 diabetes.

Wesley Nuffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31807264